Ambrx Biopharma Inc. Retained Earnings
Ambrx Biopharma Inc. had Retained Earnings of -$324.76 million as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-08-09
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$324.76M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$306.93M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$291.63M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$265.12M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-06-30 | -$324.76M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$306.93M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$291.63M 10-Q · filed 2023-08-09 |
| 2022-06-30 | -$265.12M 6-K · filed 2022-08-29 |
| 2021-12-31 | -$213.63M 10-K · filed 2023-03-30 |
| 2020-12-31 | -$145.55M 20-F · filed 2022-04-26 |